Wittekind, Charlotte E. http://orcid.org/0000-0002-5841-0067
Takano, Keisuke
Sckopke, Philipp
Winkler, Markus H.
Werner, Gabriela G.
Ehring, Thomas
Rüther, Tobias
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (WI4856/3-1)
Ludwig-Maximilians-Universität München
Article History
Received: 20 August 2021
Accepted: 7 March 2022
First Online: 21 March 2022
Declarations
:
: The trial is registered at the German Clinical Trials Register (DRKS00019221). The trial and the informed consent have been approved by the ethics committee of the Department of Psychology and Education at LMU (23_Wittekind_c_2019). All participants provide written informed consent prior to participation. Important modifications to the trial (e.g., inclusion criteria, sample size) will be communicated to the Clinical Trials Register and the ethics committee.
: Not applicable.
: CEW, KT, PS, MHW, GGW, and TE: The authors declare that they have no competing interests. TR: Pfizer Pharma, Johnson & Johnson: talks and advisory boards. Boehringer Ingelheim, Janssen-Cilag: talks.